![]() |
Volumn 23, Issue 21, 2013, Pages 5844-5849
|
Studies on substituted benzo[h]quinazolines, benzo[g]indazoles, pyrazoles, 2,6-diarylpyridines as anti-tubercular agents
|
Author keywords
Antitubercular; Diarylpyridine; Indazole; Pyrazole; Quinazoline
|
Indexed keywords
(4 (2 AMINO 8 METHOXY 5,6 DIHYDROBENZO [H] QUINAZOLIN 4 YL)PHENOXY)ALKANOATE;
(4 (2 AMINO 8 METHOXY 5,6 DIHYDROBENZO[H] QUINAZOLIN 4 YL)PHENOXY)ALKANEHYDRAZIDE;
1 (3 (4 ALKOXYPHENYL) 7 METHOXY 3,3A,4,5 TETRAHYDRO 2H BENZO[G]INDAZOL 2 YL)ETHANONE;
1 (3 (4 HYDROXYPHENYL) 7 METHOXY 3,3A,4,5 TETRAHYDRO 2H BENZO[G]INDAZOL 2 YL)ETHANONE;
1 (3 (4 HYDROXYPHENYL) 7 METHOXY 3,3A,4,5TETRAHYDRO 2H BENZO[G]INDAZOL 2 YL);
2 (4 HYDROXYBENZYLIDENE) 6METHOXY 3,4 DIHYDRO NAPHTHALEN 1(2H) ONE;
2 CYANO 5 OXO 5 PHENYL 3 PIPERIDIN 1 YL PENT 2 ENOIC ACID ETHYL ESTER;
5,6 DIHYDRO 8 METHOXYBENZO[H]QUINAZOLIN 2 AMINE;
CHALCONE;
DIOXANE DERIVATIVE;
ETHAMBUTOL;
ETHIONAMIDE;
ISONIAZID;
PYRAZINAMIDE;
PYRAZOLE DERIVATIVE;
PYRIDINE DERIVATIVE;
PYRIMIDINE DERIVATIVE;
RIFAMPICIN;
STREPTOMYCIN;
TUBERCULOSTATIC AGENT;
UNCLASSIFIED DRUG;
ANTIBACTERIAL ACTIVITY;
ARTICLE;
BACTERIAL STRAIN;
BIOLOGICAL ACTIVITY;
CYTOTOXICITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
IN VITRO STUDY;
LIPOPHILICITY;
MINIMUM INHIBITORY CONCENTRATION;
MYCOBACTERIUM TUBERCULOSIS;
STRUCTURE ACTIVITY RELATION;
MYCOBACTERIUM TUBERCULOSIS;
AFRWBGJRWRHQOV-UHFFFAOYSA-N;
AJTJGWQHYALTSC-UHFFFAOYSA-N;
AKKATVMDHBEASX-UHFFFAOYSA-N;
ANTITUBERCULAR;
AYZGFAJCOVMXLA-UHFFFAOYSA-N;
CFOCPVQZZLPMIO-UHFFFAOYSA-N;
CMWJZWOGUWCFQV-UHFFFAOYSA-N;
CTEHHBOBZOCAIT-UHFFFAOYSA-N;
CTODEFQZHRGULH-UHFFFAOYSA-N;
DBXRLXVTWNUHCR-UHFFFAOYSA-N;
DIARYLPYRIDINE;
DSCMLTAZYFVUPH-UHFFFAOYSA-N;
DSLIJABHAVBSDV-UHFFFAOYSA-N;
DWRUNZAIXLCFIP-UHFFFAOYSA-N;
DXBULVYHTICWKT-UHFFFAOYSA-N;
DXPKJYJXQICXLT-UHFFFAOYSA-N;
FIGVJXMTQDHJMQ-UHFFFAOYSA-N;
GYXWNSDLDXGMGU-UHFFFAOYSA-N;
HJBWBXRSRQEPRF-UHFFFAOYSA-N;
ICSNLGPSRYBMBD-UHFFFAOYSA-N;
IEVUNGKXTAPNJR-UHFFFAOYSA-N;
INDAZOLE;
ITENFASQOQYRFM-UHFFFAOYSA-N;
JADFRCNEVYMOAL-UHFFFAOYSA-N;
KGHNKNWLMDRAQN-UHFFFAOYSA-N;
KXDAEFPNCMNJSK-UHFFFAOYSA-N;
LFUDVFOVNMIIIB-UHFFFAOYSA-N;
LONGYNYRAPHNDS-UHFFFAOYSA-N;
LOQHWUSEIHJYSE-UHFFFAOYSA-N;
MHOUKRXEYUPHQG-UHFFFAOYSA-N;
MKOXPFXGJVHBRH-UHFFFAOYSA-N;
MMVNARZZQWUGQI-UHFFFAOYSA-N;
MZCGMLMIRVVUSZ-UHFFFAOYSA-N;
MZWNQLWLROXGST-UHFFFAOYSA-N;
NFJFJJLADCFCHO-UHFFFAOYSA-N;
NKPNESPVSMHQPA-ZRDIBKRKSA-N;
NQRYJNQNLNOLGT-UHFFFAOYSA-N;
NXWRCPFWNLSYMG-UHFFFAOYSA-N;
PAEYRUAPLGXYIJ-UHFFFAOYSA-N;
PLGIFHJDPLCSPL-UHFFFAOYSA-N;
POMGSLQHWNDZAP-UHFFFAOYSA-N;
PYRAZOLE;
QLIZWGWIQMJGMB-UHFFFAOYSA-N;
QUINAZOLINE;
QXQPWPCSFNZDEU-JLHYYAGUSA-N;
RLGJGDBTBWUXKU-UHFFFAOYSA-N;
RMGFLMXDCGQKPS-UHFFFAOYSA-N;
STGYTXNBWMZKBA-UHFFFAOYSA-N;
UBABLIWJMXJJNH-UHFFFAOYSA-N;
UPFBAUZYKBLCEO-ZRDIBKRKSA-N;
VGLWVBWXBZWXJE-WUKNDPDISA-N;
VMNKGGRIISDZAU-UHFFFAOYSA-N;
VOISDZHTKJQPAM-UHFFFAOYSA-N;
WDWWEAMPRRKLGH-UHFFFAOYSA-N;
WGCBFZZUJQDDSF-UHFFFAOYSA-N;
WJNQRYCMQPMUDS-PKNBQFBNSA-N;
WNRWEBKEQARBKV-UHFFFAOYSA-N;
WQMAANNAZKNUDL-UHFFFAOYSA-N;
XBPOBCXHALHJFP-UHFFFAOYSA-N;
XPAKBGQUORPCMO-PKNBQFBNSA-N;
XRWQAJSVMIKRKF-UHFFFAOYSA-N;
YNAVUWVOSKDBBP-UHFFFAOYSA-N;
YWQRMQADBLJRKZ-UHFFFAOYSA-N;
ZVGCJBIDARLIMB-UHFFFAOYSA-N;
ZWKKHRLWUFOSPA-UHFFFAOYSA-N;
ZXANSLBVWCBHPP-UHFFFAOYSA-N;
ANTITUBERCULAR AGENTS;
CELL LINE;
HUMANS;
INDAZOLES;
MYCOBACTERIUM TUBERCULOSIS;
PYRAZOLES;
PYRIDINES;
QUINAZOLINES;
TUBERCULOSIS;
|
EID: 84885171675
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2013.08.101 Document Type: Article |
Times cited : (50)
|
References (27)
|